Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0KC7K
|
|||
| Former ID |
DIB004257
|
|||
| Drug Name |
EC-154
|
|||
| Synonyms |
Heat shock protein 90 inhibitors (cancer), Biogen Idec; Hsp 90inhibitors (cancer), Biogen Idec
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Terminated | [1] | |
| Company |
Biogen Idec Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Inhibition of heat shock protein 90 (Hsp90) modulates macrophage stimulating-1 receptor (MSR1) expression and signaling, and reduces pancreatic tumor growth. Cancer Res May 1, 2009 69; 2835. | |||
| REF 2 | WO patent application no. 2013,1734,36, Pre-selection of subjects for therapeutic treatment with an hsp90 inhibitor based on hypoxic status. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.